Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate

Journal of Urology

Volumn 160, Issue 5, 1998, Pages 1722-1726

  Stone, Nelson N ^a   Stock, Richard G ^a   Parikh, Dhaval ^a   Yeghiayan, Paula ^a   Unger, Pamela ^a  

^a ANIMAL MEDICAL CENTER   (United States)

Author keywords

Lymph nodes; Neoplasm metastasis; Prostatic neoplasms; Seminal vesicles

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPH NODE; PERINEURIUM; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; REGRESSION ANALYSIS; SCORING SYSTEM; SEMINAL VESICLE;

EID: 0344246910     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62393-0     Document Type: Article

References (44)

1. Stone, N. N., DeAntoni, E. P., Crawford, E. D. and The Prostate Education Council: Screening for prostate cancer by digital rectal examination and prostate-specific antigen. Results of prostate cancer awareness week 1989-1992. Urology, suppl., 44: 18, 1994.
2. Crawford, E. D., DeAntoni, E. P., Etzioni, R., Schaefer, V. C., Olson, R. M., Ross, C. A. and the Prostate Education Council.: Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program. Urology, 47: 863, 1996.
3. Wolf, J. S., Jr., Shinohara, K., Kerikowske, K. M., Narayan, P., Stoller, M. and Carroll, P. R.: Selection of patients for laparoscopic pelvic lymphadenectomy prior to radical prostatectomy: a decision analysis. Urology, 42: 680, 1993.
4. Campbell, S. C., Klein, E. A., Levin, H. S. and Piedmonte, M. R.: Open pelvic lymph node dissection for prostate cancer: a reassessment. Urology, 46: 352, 1995.
5. Donohue, R. E., Mani, J. H., Whitesel, J. A., Mohr, S., Scanavina, D., Augspurger, R. R., Biber, R. J., Fauver, H. E., Wettlaufer, J. N. and Pfister, R. R.: Pelvic lymph node dissection. Guide to patient management in clinically locally confined adenocarcinoma of the prostate. Urology, 20: 559, 1982.
6. Bruce, A. W., O'Cleireachain, Morales, A. and Awad, S. A.: Carcinoma of the prostate: a critical look at staging. J. Urol., 117: 319, 1977.
7. Brendler, C.B., Cleeve, L. K., Anderson, E. F. and Paulson, D. F.: Staging pelvic lymphadenectomy for carcinoma of the prostate: risk versus benefit. J. Urol., 124: 849, 1980.
8. Nicholson, T. C. and Richie, J. P.: Pelvic lymphadenectomy for stage B1 adenocarcinoma of the prostate: justified or not? J. Urol., 117: 199, 1977.
9. O'Dowd, G. J., Veltri, R. W., Orozco, R., Miller, M. C. and Oesterling, J. E.: Update on the appropriate staging evaluation for newly diagnosed prostate cancer. J. Urol., 158: 687, 1997.
10. Gasch, A.: Monitoring firms strengthen, consolidate positions at AACN. BBI Newsletter, 20: 137, 1997.
11. Stone, N. N., Stock, R. G. and Unger, P.: Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate. J. Urol., 154: 1392, 1995.
12. Stock, R. G., Stone, N. N., Ianuzzi, C. and Unger, P.: Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer. Int. J. Rad. Oncol. Biol. Phys., 33: 815, 1995.
13. Linzer, D. G., Stock, R. G., Stone, N. N., Ratnow, R., Ianuzzi, C. and Unger, P.: Seminal vesicle biopsy: accuracy and implication for staging of prostate cancer. Urology, 48: 757, 1996.
14. Stone, N. N., Stock, R. G. and Unger, P.: Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques. J. Urol., 158: 1891, 1997.
15. Whitmore, W. F., Hilaris, B. and Grabstald, H.: Retropubic implantation of iodine 125 in the treatment of prostatic cancer. J. Urol., 108: 918, 1972.
16. Whitmore, W. F.: Interstitial radiation therapy for carcinoma of the prostate. Prostate, 1: 157, 1980.
17. Herr, H. W.: Complications of pelvic lymphadenectomy and retropubic prostatic 125I implantation. Urology, 14: 226, 1979.
18. Stock, R. G., Stone, N. N., DeWyngaert, J. K., Lavagnini, P. and Unger, P. D.: Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer, 77: 2386, 1996.
19. 125iodine implantation for stage T1/T2 prostatic carcinoma. J. Urol., 154: 1096, 1995.
20. Wallner, K., Roy, J. and Harrison, L.: Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J. Clin. Oncol., 14: 449, 1996.
21. Stone, N. N., Stock, R. G., DeWyngaert, J. K. and Tabert, A.: Prostate brachytherapy: improvements in prostate volume measurements and dose distribution using interactive ultrasound guided implantation and three-dimensional dosimetry. Rad. Oncol. Invest., 3: 185, 1995.
22. Stock, R. G. and Stone, N. N.: The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapy. Sem. Surg. Oncol., 13: 454, 1997.
23. Stone, N. N., Ramin, S. A., Wesson, M. F., Stock, R. G. and Unger, P.: Laparoscopic pelvic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed implantation of the prostate. J. Urol., 153: 1555, 1995.
24. Partin, A. W., Kattan, M. W., Subong, E. N., Walsh, P. C., Wojno, K. J., Oesterling, J. E., Scardino, P. T. and Pearson, J. D.: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. J.A.M.A., 277:1445, 1997.
25. Mukamel, E., deKernion, J. B., Hannah, J., Smith, R. B., Skinner, D. G. and Goodwin, W. E.: The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate. Cancer, 59: 1535, 1987.
26. Vallancien, G., Bochereau, G., Wetzel, O., Bretheau, D., Prapotnich, D. and Bougaran, J.: Influence of preoperative positive seminal vesicle biopsy on the staging of prostatic cancer. J. Urol., 152: 1152, 1994.
27. Egan, A. J. and Bostwick, D. G.: Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis. Amer. J. Surg. Path., 21: 1496, 1997.
28. Bostwick, D. G., Qian, J., Bergstralh, E., Dundore, P., Dugan, J., Myers, R. P. and Oesterling, J. E.: Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J. Urol., 155: 1361, 1996.
29. Bostwick, D. G.: Gleason grading of prostate needle biopsies. Correlation with grade in 316 matched prostatectomies. Amer. J. Surg. Path., 18: 796, 1994.
30. Villers, A., McNeal, J. E., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J. Urol., 142: 763, 1989.
31. Bastacky, S. I., Walsh, P. C. and Epstein, J. I.: Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Amer. J. Surg. Path., 17: 336, 1993.
32. Bonin, S. R., Hanlon, A. L., Lee, W. R., Movsas, B., al-Saleem, T. I. and Hanks, G. E.: Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy. Cancer, 79: 75, 1997.
33. Epstein, J. I., Oesterling, J. E., Eggleston, J. C. and Walsh, P. C.: Frozen section detection of lymph node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimens. J. Urol., 136: 1234, 1986.
34. Catalona, W. J. and Stein, A. J.: Accuracy of frozen section detection of lymph node metastases in prostatic carcinoma. J. Urol., 127: 460, 1981.
35. Gervasi, L. A., Mata, J., Easley, J. D., Wilbanks, J. H., Seale-Hawkins, C., Carlton, C. E., Jr. and Scardino, P. T.: Prognostic significance of lymph nodal metastases in prostate cancer. J. Urol., 142: 332, 1989.
36. Kramer, S. A., Cline, W. A., Jr., Farnham, R., Carson, C. C., Cox, E. B., Hinshaw, W. and Paulson, D. F.: Prognosis of patients with stage D1 prostatic adenocarcinoma. J. Urol., 125: 817, 1981.
37. Leibel, S., Fuks, Z., Zelefsky, M. and Whitmore, W. F., Jr.: The effect of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement. Int. J. Rad. Oncol. Biol. Phys., 28: 7, 1994.
38. Paulson, D. F., Cline, W. A., Jr., Koefoot, R. B., Jr., Hinshaw, W., Stephani, S. and the Uro-Oncology Group: Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma. J. Urol., 127: 935, 1982.
39. Smith, J. A., Jr., Haynes, T. H. and Middleton, R. G.: Impact of external irradiation on local symptoms and survival free of disease in patients with pelvic lymph node metastases from adenocarcinoma of the prostate. J. Urol., 131: 705, 1984.
40. Steinberg, G. D., Epstein, J. I., Piantadosi, S. and Walsh, P. C.: Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experiences 1974 to 1987. J. Urol., 144: 1425, 1990.
41. Frazier, H. A., II, Robertson, J. E. and Paulson, D. F.: Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival? World J. Urol., 12: 308, 1994.
42. Parra, R. O., Andrus, C. and Boullier, J.: Staging laparoscopic pelvic lymph node dissection: comparison of results with open pelvic lymphadenectomy. J. Urol., 147: 875, 1992.
43. Schuessler, W. W., Vancaillie, T. G., Reich, H. and Griffith, D. P.: Transperitoneal endosurgical lymphadenectomy in patients with localized prostate cancer. J. Urol., 145: 988, 1991.
44. Rukstalis, D. B., Gergber, G. S., Vogelzang, N. J., Haraf, D. J., Strauss, F. H., Jr. and Chodak, G. W.: Laparoscopic pelvic lymph node dissection: A review of 103 cases. J. Urol., 151: 640, 1994.